Streptococcus Pneumoniae – epidemiology, risk factors and evolution of antimicrobial resistance
Închide
Articolul precedent
Articolul urmator
514 7
Ultima descărcare din IBN:
2020-04-17 11:02
SM ISO690:2012
BALAN, Greta; PUŞCAŞ, Nicolae; BURDUNIUC, Aurelia; SPÎNU, Constantin; BURDUNIUC (POPA), Olga; BORTĂ, Vasile; RUDIC, Valeriu. Streptococcus Pneumoniae – epidemiology, risk factors and evolution of antimicrobial resistance. In: Microbial Biotechnology. Ediția 3, 12-13 octombrie 2016, Chișinău. Chișinău, Republica Moldova: Institutul de Microbiologie şi Biotehnologie, 2016, pp. 18-23.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Microbial Biotechnology
Ediția 3, 2016
Conferința "Microbial Biotechnology"
Chișinău, Moldova, 12-13 octombrie 2016

Streptococcus Pneumoniae – epidemiology, risk factors and evolution of antimicrobial resistance


Pag. 18-23

Balan Greta12, Puşcaş Nicolae1, Burduniuc Aurelia1, Spînu Constantin2, Burduniuc (Popa) Olga2, Bortă Vasile1, Rudic Valeriu13
 
1 Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“,
2 Centrul Naţional de Sanătate Publică,
3 Institutul de Microbiologie şi Biotehnologie al AŞM
 
Disponibil în IBN: 13 martie 2019


Rezumat

Streptococcus pneumoniae (pneumococcus) remains an important cause of pneumonia, meningitis, bacteremias, and acute otitis media worldwide. Antimicrobial resistance among pneumococci has escalated dramatically over the past three decades, and is influenced by patterns of antibiotic use, population density, and spread of a few international clones. Globally, antimicrobial resistance among pneumococci spread rapidly in the 1990s, reflecting dissemination of a few clones. The incidence of resistance varies considerably among different geographic regions and is influenced by patterns of antibiotic use, population density, and local prevalence of resistant strains. The use of specific antibiotic classes not only predisposes to resistance to that class but also may facilitate the emergence of resistance to unrelated antibiotic classes. Cautious usage of antibiotics may reduce the incidence of antibiotic-resistant pneumococci.

Cuvinte-cheie
Streptococcus pneumoniae, antimicrobial resistance, risk factors